Comparison of Antinociceptive Effects of Ketamine and Magnesium Used for Sedation in Hysteroscopy Cases
Launched by SULEYMAN SARI · Dec 17, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Sedation is generally preferred in hysteroscopy cases. The most commonly used intravenous drugs are midazolam, fentanyl, propofol and remifentanil. Multimodal analgesia, which is intended to be provided in hysteroscopy cases, is a strategy that includes the use of two or more analgesic agents and techniques to provide adequate analgesia; and aims to minimize side effects such as bradycardia, hypotension, respiratory depression, pruritus, and postoperative nausea and vomiting. Multimodal analgesia improves patient and surgical comfort by applying additional drugs to existing agents, reduces ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. ASA I-II patients
- • 2. Patients aged 18-55
- • 3. Patients undergoing hysteroscopy
- Exclusion Criteria:
- • 1. Patients who develop surgical complications during hysteroscopy
- • 2. Patients with cardiovascular failure (ejection fraction \<40%, patients with atrioventricular conduction disorder
- • 3. Patients with history of cerebrovascular disease
- • 4. Liver dysfunction (transaminases above normal level), Renal failure (creatine \> 150 μmol/L),
- • 5. Preoperative opioid use
- • 6. History of neuromuscular disease
- • 7. History of drug or alcohol abuse
- • 8. Patients who develop the need for endotracheal intubation
About Suleyman Sari
Suleyman Sari is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing cutting-edge therapies, the organization collaborates with leading researchers and institutions to conduct rigorous clinical trials that adhere to the highest ethical and regulatory standards. Suleyman Sari is driven by a mission to improve patient outcomes and enhance healthcare solutions through comprehensive study designs, meticulous data analysis, and a commitment to transparency throughout the research process. Their expertise spans various therapeutic areas, reflecting a strong dedication to addressing unmet medical needs and fostering scientific progress.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported